BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.830
-0.070 (-2.41%)
At close: Jul 20, 2026, 4:00 PM EDT
2.830
0.00 (0.00%)
After-hours: Jul 20, 2026, 4:10 PM EDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $12.88 million as of July 20, 2026. Its market cap has decreased by -32.38% in one year.
Market Cap
12.88M
Enterprise Value
8.62M
1-Year Change
-32.38%
Ranking
Category
Stock Price
$2.83
ChartMarket Cap Chart
Since July 25, 2011, BioLineRx's market cap has decreased from $68.58M to $12.88M, a decrease of -81.22%. That is a compound annual growth rate of -10.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 12.07M | -7.85% |
| Dec 31, 2025 | 13.10M | -44.21% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 13.10M |
| IN8bio | 13.10M |
| Intensity Therapeutics | 12.84M |
| GT Biopharma | 12.83M |
| Lunai Bioworks | 12.79M |
| Phio Pharmaceuticals | 11.97M |
| CytoMed Therapeutics | 11.83M |
| Psyence Biomedical | 11.71M |